nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—polycystic ovary syndrome	0.814	1	CbGaD
Albendazole—CYP1A2—urine—polycystic ovary syndrome	0.00729	0.0731	CbGeAlD
Albendazole—TUBA1A—embryo—polycystic ovary syndrome	0.00623	0.0625	CbGeAlD
Albendazole—CYP3A4—urine—polycystic ovary syndrome	0.00528	0.0529	CbGeAlD
Albendazole—TUBA1A—adrenal cortex—polycystic ovary syndrome	0.00511	0.0512	CbGeAlD
Albendazole—TUBA1A—endometrium—polycystic ovary syndrome	0.00456	0.0457	CbGeAlD
Albendazole—TUBA1A—uterus—polycystic ovary syndrome	0.0042	0.0421	CbGeAlD
Albendazole—TUBB4B—embryo—polycystic ovary syndrome	0.00415	0.0416	CbGeAlD
Albendazole—TUBA1A—pituitary gland—polycystic ovary syndrome	0.00413	0.0414	CbGeAlD
Albendazole—TUBA1A—adipose tissue—polycystic ovary syndrome	0.00411	0.0412	CbGeAlD
Albendazole—TUBA1A—adrenal gland—polycystic ovary syndrome	0.00369	0.0369	CbGeAlD
Albendazole—TUBA1A—female gonad—polycystic ovary syndrome	0.00344	0.0344	CbGeAlD
Albendazole—TUBA1A—vagina—polycystic ovary syndrome	0.00342	0.0342	CbGeAlD
Albendazole—TUBB4B—adrenal cortex—polycystic ovary syndrome	0.0034	0.0341	CbGeAlD
Albendazole—TUBA1A—endocrine gland—polycystic ovary syndrome	0.0032	0.032	CbGeAlD
Albendazole—TUBB4B—endometrium—polycystic ovary syndrome	0.00304	0.0305	CbGeAlD
Albendazole—Mebendazole—CYP1A1—polycystic ovary syndrome	0.0029	1	CrCbGaD
Albendazole—TUBB4B—uterus—polycystic ovary syndrome	0.0028	0.0281	CbGeAlD
Albendazole—TUBB4B—pituitary gland—polycystic ovary syndrome	0.00275	0.0276	CbGeAlD
Albendazole—TUBB4B—adipose tissue—polycystic ovary syndrome	0.00274	0.0275	CbGeAlD
Albendazole—TUBB4B—adrenal gland—polycystic ovary syndrome	0.00246	0.0246	CbGeAlD
Albendazole—TUBB4B—female gonad—polycystic ovary syndrome	0.00229	0.023	CbGeAlD
Albendazole—TUBB4B—vagina—polycystic ovary syndrome	0.00228	0.0228	CbGeAlD
Albendazole—TUBB4B—endocrine gland—polycystic ovary syndrome	0.00213	0.0214	CbGeAlD
Albendazole—CYP1A1—uterus—polycystic ovary syndrome	0.00157	0.0157	CbGeAlD
Albendazole—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00153	0.0154	CbGeAlD
Albendazole—CYP1A1—female gonad—polycystic ovary syndrome	0.00128	0.0129	CbGeAlD
Albendazole—CYP1A1—vagina—polycystic ovary syndrome	0.00127	0.0128	CbGeAlD
Albendazole—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00121	0.0121	CbGeAlD
Albendazole—ABCB1—embryo—polycystic ovary syndrome	0.00121	0.0121	CbGeAlD
Albendazole—CYP1A1—endocrine gland—polycystic ovary syndrome	0.00119	0.012	CbGeAlD
Albendazole—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00099	0.00992	CbGeAlD
Albendazole—ABCB1—endometrium—polycystic ovary syndrome	0.000884	0.00886	CbGeAlD
Albendazole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000875	0.00877	CbGeAlD
Albendazole—ABCB1—uterus—polycystic ovary syndrome	0.000815	0.00816	CbGeAlD
Albendazole—ABCB1—pituitary gland—polycystic ovary syndrome	0.0008	0.00802	CbGeAlD
Albendazole—ABCB1—adipose tissue—polycystic ovary syndrome	0.000797	0.00798	CbGeAlD
Albendazole—ABCB1—adrenal gland—polycystic ovary syndrome	0.000715	0.00716	CbGeAlD
Albendazole—ABCB1—female gonad—polycystic ovary syndrome	0.000666	0.00668	CbGeAlD
Albendazole—ABCB1—vagina—polycystic ovary syndrome	0.000662	0.00664	CbGeAlD
Albendazole—ABCB1—endocrine gland—polycystic ovary syndrome	0.00062	0.00621	CbGeAlD
Albendazole—CYP1A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000147	0.00175	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	0.000143	0.00171	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000142	0.00169	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000142	0.00169	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000142	0.00169	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000141	0.00168	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.00014	0.00167	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000139	0.00166	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000139	0.00166	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000138	0.00165	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000136	0.00162	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000136	0.00162	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000135	0.00161	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000134	0.0016	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000134	0.0016	CbGpPWpGaD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000133	0.00159	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000133	0.00159	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000132	0.00157	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000129	0.00154	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000128	0.00153	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000124	0.00147	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00012	0.00144	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.00012	0.00143	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000119	0.00142	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000118	0.00141	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000116	0.00139	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000116	0.00138	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000115	0.00138	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000114	0.00136	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000114	0.00136	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000114	0.00136	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000114	0.00136	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000111	0.00133	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000111	0.00133	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000109	0.00131	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000109	0.0013	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000109	0.0013	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000108	0.00129	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000108	0.00129	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000107	0.00128	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000105	0.00125	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000103	0.00123	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000103	0.00123	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—PPARG—polycystic ovary syndrome	0.000103	0.00123	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000102	0.00122	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000102	0.00122	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—INS—polycystic ovary syndrome	0.000102	0.00121	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000101	0.0012	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000101	0.0012	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	0.000101	0.0012	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—IGF1—polycystic ovary syndrome	9.85e-05	0.00117	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	9.67e-05	0.00115	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	9.54e-05	0.00114	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.52e-05	0.00114	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.5e-05	0.00113	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.37e-05	0.00112	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.9e-05	0.00106	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.81e-05	0.00105	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.78e-05	0.00105	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.75e-05	0.00104	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	8.65e-05	0.00103	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	8.65e-05	0.00103	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.51e-05	0.00101	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	8.43e-05	0.00101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NMNAT3—polycystic ovary syndrome	8.36e-05	0.000997	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	8.15e-05	0.000973	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.1e-05	0.000966	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.98e-05	0.000951	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.89e-05	0.000941	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.8e-05	0.00093	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.78e-05	0.000928	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	7.65e-05	0.000913	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LPCAT2—polycystic ovary syndrome	7.65e-05	0.000912	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SUOX—polycystic ovary syndrome	7.65e-05	0.000912	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.55e-05	0.000901	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.52e-05	0.000897	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.42e-05	0.000885	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.35e-05	0.000876	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.33e-05	0.000875	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.25e-05	0.000865	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.23e-05	0.000863	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—LEP—polycystic ovary syndrome	7.19e-05	0.000858	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	7.18e-05	0.000856	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ISYNA1—polycystic ovary syndrome	7.11e-05	0.000848	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—POMC—polycystic ovary syndrome	7.09e-05	0.000845	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.95e-05	0.000829	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	6.93e-05	0.000827	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	6.88e-05	0.00082	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	6.68e-05	0.000797	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	6.63e-05	0.000791	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.57e-05	0.000783	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.56e-05	0.000782	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.49e-05	0.000774	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—POMC—polycystic ovary syndrome	6.18e-05	0.000737	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.16e-05	0.000734	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—INS—polycystic ovary syndrome	6.15e-05	0.000733	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	6.11e-05	0.000729	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	6.11e-05	0.000729	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.06e-05	0.000723	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	6.05e-05	0.000721	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	6.05e-05	0.000721	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.98e-05	0.000713	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—IGF1—polycystic ovary syndrome	5.95e-05	0.000709	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.81e-05	0.000693	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.8e-05	0.000692	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.72e-05	0.000683	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.72e-05	0.000683	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	5.68e-05	0.000677	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.58e-05	0.000665	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	5.33e-05	0.000636	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.09e-05	0.000607	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	5.07e-05	0.000604	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	5.01e-05	0.000597	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.97e-05	0.000593	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	4.88e-05	0.000582	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	4.88e-05	0.000582	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.83e-05	0.000576	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.83e-05	0.000576	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.81e-05	0.000574	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	4.8e-05	0.000573	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.68e-05	0.000558	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.61e-05	0.00055	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	4.58e-05	0.000546	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	4.53e-05	0.000541	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.53e-05	0.00054	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	4.52e-05	0.000539	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.43e-05	0.000528	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.37e-05	0.000521	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.3e-05	0.000513	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.14e-05	0.000493	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.11e-05	0.000491	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	4.08e-05	0.000487	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	4.05e-05	0.000483	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4e-05	0.000477	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.92e-05	0.000468	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.9e-05	0.000465	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	3.85e-05	0.00046	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	3.85e-05	0.00046	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.85e-05	0.000459	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.84e-05	0.000458	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.76e-05	0.000449	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.76e-05	0.000449	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.71e-05	0.000442	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.66e-05	0.000436	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.66e-05	0.000436	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.65e-05	0.000435	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	3.55e-05	0.000424	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.5e-05	0.000417	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.49e-05	0.000416	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.47e-05	0.000414	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.36e-05	0.000401	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.27e-05	0.00039	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.26e-05	0.000389	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.23e-05	0.000385	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.11e-05	0.000371	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.09e-05	0.000369	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.07e-05	0.000366	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.06e-05	0.000365	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	3e-05	0.000357	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.97e-05	0.000355	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.97e-05	0.000355	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.92e-05	0.000348	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.89e-05	0.000345	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.89e-05	0.000344	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.84e-05	0.000338	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.78e-05	0.000331	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.77e-05	0.000331	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.76e-05	0.000329	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.74e-05	0.000327	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.72e-05	0.000325	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.69e-05	0.00032	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.6e-05	0.000311	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.59e-05	0.000309	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.55e-05	0.000304	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.49e-05	0.000297	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.48e-05	0.000296	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.47e-05	0.000295	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.46e-05	0.000293	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.39e-05	0.000286	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.36e-05	0.000282	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.33e-05	0.000278	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.31e-05	0.000275	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.26e-05	0.00027	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.25e-05	0.000269	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.22e-05	0.000264	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.21e-05	0.000264	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TH—polycystic ovary syndrome	2.21e-05	0.000263	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.19e-05	0.000261	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.14e-05	0.000256	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.14e-05	0.000256	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.07e-05	0.000247	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.04e-05	0.000243	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.02e-05	0.000241	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.01e-05	0.00024	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.97e-05	0.000235	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.92e-05	0.000229	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.91e-05	0.000228	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.84e-05	0.00022	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.8e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.77e-05	0.000211	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.76e-05	0.00021	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.76e-05	0.00021	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.75e-05	0.000209	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.75e-05	0.000208	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.74e-05	0.000207	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.71e-05	0.000205	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.71e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.71e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.65e-05	0.000197	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.65e-05	0.000197	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.62e-05	0.000194	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.61e-05	0.000192	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.52e-05	0.000182	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.52e-05	0.000181	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.47e-05	0.000176	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.44e-05	0.000171	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.42e-05	0.00017	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.41e-05	0.000168	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.37e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.37e-05	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.37e-05	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.35e-05	0.000161	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.3e-05	0.000155	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.29e-05	0.000153	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.27e-05	0.000152	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.25e-05	0.00015	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	1.23e-05	0.000147	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	1.21e-05	0.000145	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.21e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—INS—polycystic ovary syndrome	1.21e-05	0.000144	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	0.000137	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.09e-05	0.00013	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.09e-05	0.000129	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.06e-05	0.000126	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	0.000124	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.92e-06	0.000118	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	9.82e-06	0.000117	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—polycystic ovary syndrome	9.68e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	9.66e-06	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—INS—polycystic ovary syndrome	9.63e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.86e-06	0.000106	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.44e-06	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8e-06	9.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	7.84e-06	9.35e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	7.73e-06	9.22e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—INS—polycystic ovary syndrome	7.69e-06	9.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.46e-06	8.9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.05e-06	7.21e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.96e-06	7.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.93e-06	7.07e-05	CbGpPWpGaD
